Oxytocin 48iu (DrugBank: Oxytocin)
5 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 0 |
127 | Frontotemporal lobar degeneration | 0 |
193 | Prader-Willi syndrome | 0 |
206 | Fragile X syndrome | 1 |
226 | Interstitial cystitis with Hunners ulcer | 0 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01254045 (ClinicalTrials.gov) | February 2007 | 2/12/2010 | Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome | Double-blind Placebo Controlled Study of Oxytocin in Fragile X Syndrome | Fragile X Syndrome | Drug: placebo;Drug: oxytocin 24IU;Drug: oxytocin 48IU | Stanford University | NULL | Completed | 13 Years | 29 Years | Male | 10 | Phase 2 | United States |